Finance

Lists
Q2 2027 earnings • released • Revenue miss -9.24%
See results
4980:TYO
Dexerials Corp
¥2,067.00
-4.64%
(-100.50) 1D
Nov 13, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4980...
Open
¥2,160
High
¥2,209
Low
¥2,052
Mkt. cap
361.19B
Avg. vol.
2.23M
Volume
5.19M
Dividend
2.81%
Quarterly dividend
¥14
Ex-dividend date
Sep 29, 2026
P/E ratio
13.43
52-wk high
¥5,228
52-wk low
¥2,052
EPS
¥154
Shares outstanding
60.58M
No. of employees
2K
Open
¥2,160
High
¥2,209
Low
¥2,052
Mkt. cap
361.19B
Avg. vol.
2.23M
Volume
5.19M
Dividend
2.81%
Quarterly dividend
¥14
Ex-dividend date
Sep 29, 2026
P/E ratio
13.43
52-wk high
¥5,228
52-wk low
¥2,052
EPS
¥154
Shares outstanding
60.58M
No. of employees
2K
News stories
From web sources and news partners
Profile
Sony Chemicals Corporation was a Japanese company established 1962, and was a wholly owned subsidiary of Sony Corporation. In 2008, Sony Chemical & Information Device transferred its thermal transfer ink ribbon business to Dai Nippon Printing. In 2012, Sony Chemicals Corporation was separated from Sony Group and renamed Dexerials Corporation. As of 2024, The Master Trust Bank of Japan, Ltd. is the largest shareholder of the corporation. Wikipedia
About Dexerials Corp
CEO-
Employees1.8K
Founded1962
Headquarters-
SectorInformation Technology
IndustryComputer hardware
Last report
Nov 11, 2026
Fiscal period
Q2 2027
- / -
Revenue / Est. (JPY)
28.78B / 31.71B
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
29.84B
26.54B
27.18B
28.78B
Cost of goods sold
12.31B
12.38B
12.09B
12.52B
Cost of revenue
12.31B
12.38B
12.09B
12.52B
Research and development expenses
-
6.74B
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.22B
-1.84B
6.81B
6.83B
Operating expense
6.99B
5.50B
6.50B
7.24B
Total operating expenses
19.29B
17.89B
18.59B
19.76B
Operating income
10.55B
8.65B
8.59B
9.02B
Other non operating income
194.00M
-1.00M
-
-
EBT including unusual items
10.76B
7.83B
8.70B
8.79B
EBT excluding unusual items
10.76B
8.14B
8.70B
8.79B
Income tax expense
2.91B
1.09B
2.46B
2.39B
Effective tax rate
27.01%
13.90%
28.30%
27.20%
Other operating expenses
770.00M
-768.00M
-313.00M
406.00M
Net income
7.86B
6.74B
6.24B
6.40B
Net profit margin
26.33%
25.41%
22.96%
22.23%
Earnings per share
-
-
-
-
Interest and investment income
7.00M
168.00M
23.00M
33.00M
Interest expense
-205.00M
-
-91.00M
-306.00M
Net interest expenses
-198.00M
168.00M
-68.00M
-273.00M
Depreciation and amortization charges
-
1.38B
-
-
EBITDA
-
10.55B
10.49B
11.31B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps